🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

5.977.099

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 2 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
14/09/2022 0,7300 USD
14/06/2022 0,7300 USD
14/03/2022 0,7300 USD
14/12/2021 0,7100 USD
14/09/2021 0,7100 USD
14/06/2021 0,7100 USD
12/03/2021 0,7100 USD
14/12/2020 0,6800 USD
14/09/2020 0,6800 USD
11/06/2020 0,6800 USD
12/03/2020 0,6800 USD
12/12/2019 0,6300 USD
12/09/2019 0,6300 USD
13/06/2019 0,6300 USD
14/03/2019 0,6300 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/08/2017 72,83 74,68 72,83 73,90 +0,86% 2,54% 12.054.600
08/08/2017 73,42 73,67 72,81 73,27 -0,23% 1,17% 7.943.900
07/08/2017 72,80 73,50 72,28 73,44 +0,38% 1,68% 7.556.500
04/08/2017 73,73 73,76 72,58 73,16 -1,63% 1,60% 14.960.900
03/08/2017 75,77 76,00 74,30 74,37 -1,94% 2,24% 11.161.100
02/08/2017 75,54 75,90 75,17 75,84 +0,18% 0,97% 7.086.200
01/08/2017 76,35 76,36 75,52 75,70 -0,51% 1,10% 7.296.600
31/07/2017 76,00 76,49 75,83 76,09 +0,20% 0,87% 7.994.100
28/07/2017 75,01 76,03 74,75 75,94 +1,31% 1,71% 8.954.600
27/07/2017 75,43 75,99 74,45 74,96 +1,04% 2,04% 13.871.000
26/07/2017 74,10 74,27 73,62 74,19 +0,61% 0,88% 10.695.300
25/07/2017 74,72 75,29 73,62 73,74 -0,87% 2,24% 9.061.200
24/07/2017 73,70 74,42 73,19 74,39 +0,85% 1,67% 8.943.200
21/07/2017 73,32 74,41 73,28 73,76 +0,46% 1,54% 8.874.000
20/07/2017 72,86 73,74 72,77 73,42 +0,96% 1,33% 9.271.400
19/07/2017 72,00 72,74 71,77 72,72 +1,44% 1,35% 8.312.400
18/07/2017 71,30 71,73 70,72 71,69 +0,76% 1,42% 6.096.700
17/07/2017 70,58 71,86 70,40 71,15 +0,82% 2,07% 7.612.400
14/07/2017 70,74 71,03 70,42 70,57 -0,01% 0,86% 5.234.600
13/07/2017 69,99 70,98 69,52 70,58 +1,12% 2,09% 7.533.900
12/07/2017 69,77 70,13 69,61 69,80 +0,65% 0,75% 5.585.200
11/07/2017 68,99 69,50 68,61 69,35 +0,09% 1,29% 6.442.700
10/07/2017 69,24 69,74 69,12 69,29 +0,06% 0,90% 6.485.900
07/07/2017 69,69 69,69 68,54 69,25 -0,33% 1,65% 6.535.800
06/07/2017 70,66 70,74 69,19 69,48 -1,95% 2,19% 7.989.000
05/07/2017 70,83 71,29 70,16 70,86 +0,23% 1,60% 7.219.600
03/07/2017 71,11 71,60 70,56 70,70 -0,11% 1,46% 3.453.000
30/06/2017 71,56 71,64 70,32 70,78 -0,11% 1,84% 6.727.100
29/06/2017 72,00 72,17 70,02 70,86 -1,47% 2,99% 11.437.400
28/06/2017 70,97 72,09 70,83 71,92 +1,80% 1,78% 10.606.200